Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-122328
Filing Date
2024-11-06
Accepted
2024-11-06 16:15:21
Documents
46
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q alec-20240930.htm   iXBRL 10-Q 1885595
2 EX-31.1 alec-ex31_1.htm EX-31.1 21334
3 EX-31.2 alec-ex31_2.htm EX-31.2 21331
4 EX-32.1 alec-ex32_1.htm EX-32.1 8572
5 EX-32.2 alec-ex32_2.htm EX-32.2 8551
  Complete submission text file 0000950170-24-122328.txt   5354696

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT alec-20240930.xsd EX-101.SCH 678269
49 EXTRACTED XBRL INSTANCE DOCUMENT alec-20240930_htm.xml XML 635078
Mailing Address 131 OYSTER POINT BLVD., SUITE 600 SOUTH SAN FRANCISCO CA 94080
Business Address 131 OYSTER POINT BLVD., SUITE 600 SOUTH SAN FRANCISCO CA 94080 415-231-5660
Alector, Inc. (Filer) CIK: 0001653087 (see all company filings)

EIN.: 822933343 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38792 | Film No.: 241431149
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)